Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Piramal Enterprises

Sector: Healthcare | Industry: Drugs & Pharma
R 1,375.85 -0.65  | -0.05% -38.78% 13.73 27,353.33
NSE Price: Oct 15, 15:58 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 15, 15:58 1,375.85 -0.65 -0.05% 1,365.00 1,376.50 1,215,115 1,356.55 - 1,396.40
BSE Oct 15, 2019 1,375.60 -1.25 -0.09% 1,368.00 1,376.85 91,516 1,302.00 - 1,396.10
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER

Back to Top


Chairman's Speech

As on Mar-18
Download PDF

Directors' Report

As on Mar-18
Download PDF

Management Discussion

As on Mar-18
Download PDF

Corporate Governance

As on Mar-18
Download PDF

Auditors' Report

As on Mar-18
Download PDF

Notes to Accounts Statement

As on Mar-18
Download PDF
Essential checks
Altman Z-Score
0.84
Piotroski F-Score
2
Modified C-Score
2
5-Years Price to Earnings
13.73
5-Years Price to Book
0.87
Earnings Yield
EBIT / Enterprise value
9.33%
PEG
Price / Earnings to growth ratio
-1.72
Related Stocks
  Current Price   Chng %
Abbott India R10,917.90 -0.74%
Alkem Laboratories R1,915.10 -1.38%
Biocon R260.30 +2.74%
Cadila Healthcare R234.45 +0.75%
Cipla R446.55 +1.28%
Glaxosmithkline Pharma R1,433.15 +2.66%
Lupin R721.15 +0.66%
Pfizer R3,193.15 +0.75%
Sanofi India R5,893.10 +0.23%
Torrent Pharmaceuticals R1,699.85 +0.11%
As on Oct 15, 15:59